Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Report 2026
Global Outlook – By Product Type (High Protein Foods, Glucagon Like Peptide One Optimized Meal Kits, Nutritional Supplements, Functional Beverages, Low Calorie Snacks), By Consumer (Glucagon Like Peptide One Drug Users, Weight Management Seekers, Diabetic Patients, General Wellness Consumers), By Formulation Focus (Satiety Support Products, Muscle Maintenance Products, Micronutrient Enhanced Products, Hydration Support Products, Digestive Comfort Products), By Distribution Channel (Retail Pharmacies, Electronic Commerce, Specialty Health Stores, Direct To Consumer) – Market Size, Trends, Strategies, and Forecast to 2030
Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Report 2026 Market Overview
• Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Report 2026 market size has reached to $3.2 billion in 2025 • Expected to grow to $11.66 billion in 2030 at a compound annual growth rate (CAGR) of 29.6% • Growth Driver: The Increasing Prevalence Of Obesity Driving The Growth Of The Market Due To Unhealthy Dietary Habits • Market Trend: Protein- And Fiber-Enriched Nutritional Support Solutions For Weight-Loss Therapy Users • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market?
Glucagon-like peptide-1 (GLP-1) companion food and nutrition refers to specialized dietary products and nutritional strategies designed to support and enhance the effectiveness of GLP-1–based therapies used for weight management and metabolic health. These foods and formulations typically focus on improving satiety, stabilizing blood glucose levels, and complementing the physiological actions of GLP-1 hormones. The main product types of glucagon-like peptide-1 (GLP) companion food and nutrition include high protein foods, glucagon like peptide one optimized meal kits, nutritional supplements, functional beverages, and low calorie snacks. High protein foods refer to nutrition products formulated with elevated protein content to support satiety, muscle maintenance, and nutritional balance. These products are designed for consumers including glucagon like peptide one drug users, weight management seekers, diabetic patients, and general wellness consumers. They focus on formulations such as satiety support products, muscle maintenance products, micronutrient enhanced products, hydration support products, and digestive comfort products and are distributed through retail pharmacies, electronic commerce, specialty health stores, and direct to consumer channels.
What Is The Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Size and Share 2026?
The glucagon-like peptide-1 (GLP) companion food and nutrition market size has grown exponentially in recent years. It will grow from $3.2 billion in 2025 to $4.14 billion in 2026 at a compound annual growth rate (CAGR) of 29.2%. The growth in the historic period can be attributed to rising prevalence of obesity and type 2 diabetes globally, increasing adoption of pharmacological weight management therapies, growth in functional food and dietary supplement industry, early clinical success of GLP-1 receptor agonist drugs, increasing consumer awareness of metabolic health management.What Is The Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Growth Forecast?
The glucagon-like peptide-1 (GLP) companion food and nutrition market size is expected to see exponential growth in the next few years. It will grow to $11.66 billion in 2030 at a compound annual growth rate (CAGR) of 29.6%. The growth in the forecast period can be attributed to expansion of GLP-1 drug adoption for weight and diabetes care, rising demand for personalized nutrition and precision diet planning, growth of digital health and nutrition tracking platforms, increasing integration of food-tech and biotech innovations, expansion of preventive healthcare and metabolic wellness programs. Major trends in the forecast period include personalized metabolic nutrition planning for GLP-1 therapy support, satiety-enhancing functional food formulations with appetite regulation focus, low glycemic index meal systems designed for glucose stabilization, microbiome optimized dietary interventions for weight management support, protein enriched and nutrient dense GLP-1 companion diets for muscle preservation.
Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Segmentation
1) By Product Type: High Protein Foods, Glucagon Like Peptide One Optimized Meal Kits, Nutritional Supplements, Functional Beverages, Low Calorie Snacks 2) By Consumer: Glucagon Like Peptide One Drug Users, Weight Management Seekers, Diabetic Patients, General Wellness Consumers 3) By Formulation Focus: Satiety Support Products, Muscle Maintenance Products, Micronutrient Enhanced Products, Hydration Support Products, Digestive Comfort Products 4) By Distribution Channel: Retail Pharmacies, Electronic Commerce, Specialty Health Stores, Direct To Consumer Subsegments: 1) By High Protein Foods: Protein Shakes, Protein Bars, High Protein Dairy Products, Protein Enriched Bakery Products, Plant Based Protein Foods 2) By Glucagon Like Peptide One Optimized Meal Kits: Calorie Controlled Meal Kits, Diabetes Friendly Meal Kits, Portion Controlled Prepared Meals, Appetite Support Meal Plans, Metabolic Health Meal Kits 3) By Nutritional Supplements: Vitamins And Minerals Supplements, Fiber Supplements, Amino Acid Supplements, Gut Health Probiotics, Weight Management Supplements 4) By Functional Beverages: Protein Beverages, Electrolyte Drinks, Fiber Infused Drinks, Low Sugar Functional Juices, Metabolic Health Drinks 5) By Low Calorie Snacks: Low Calorie Protein Snacks, Baked Snack Alternatives, Sugar Free Confectionery, Diet Friendly Savory Snacks, Portion Controlled Snack PacksWhat Is The Driver Of The Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market?
The increasing prevalence of obesity is expected to propel the growth of the glucagon-like peptide-1 (GLP) companion food and nutrition market going forward. Obesity refers to a medical condition characterized by excessive accumulation of body fat that may negatively affect health and increase the risk of diseases such as diabetes, heart disease, and hypertension. The increasing prevalence of obesity is primarily due to unhealthy dietary habits, including excessive consumption of high-calorie, processed, and sugary foods combined with low physical activity levels. Glucagon-like peptide-1 (GLP) companion food and nutrition helps in obesity management by supporting GLP-1–based weight-loss therapies through high-protein, high-fiber nutritional formulations that enhance satiety, reduce overeating, and help preserve lean muscle mass during calorie reduction. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the increasing prevalence of obesity is driving the growth of the oral glucagon-like peptide-1 (GLP) companion food and nutrition industry.Key Players In The Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market
Major companies operating in the glucagon-like peptide-1 (glp) companion food and nutrition market report are Nestlé S.A., Danone S.A., Arla Foods amba, Glanbia plc, Herbalife Ltd., BellRing Brands Inc., The Simply Good Foods Company
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Trends and Insights
Major companies operating in the glucagon-like peptide-1 (GLP) companion food and nutrition market are focusing on developing innovative nutritional support solutions, such as protein and fiber-enriched companion food combinations to enhance dietary balance, prevent muscle loss, and address potential nutrient deficiencies associated with GLP-1-based weight-loss therapies. Protein and fiber-enriched companion food combinations are specially designed food products that provide higher levels of protein and dietary fiber to help support nutrition, satiety, and digestive health, especially for people with reduced food intake or specific dietary needs. For instance, in February 2024, Herbalife Ltd., a US-based nutrition and wellness company, launched Herbalife GLP-1 Nutrition Companion, a range of food and supplement product combinations designed to support individuals using GLP-1 and other weight-loss medications. The product line includes protein shake-based formulations and fiber-enriched nutrition blends aimed at helping users meet daily nutritional requirements while supporting muscle maintenance and digestive health. The solution also integrates community-based nutritional guidance through distributors to encourage healthier eating habits during and after weight-loss treatment, ensuring sustained lifestyle improvement beyond medication use.What Are Latest Mergers And Acquisitions In The Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market?
In March 2023, WeightWatchers International Inc., a US-based wellness company, acquired Sequence Weekend Health Inc. for $132 million. Through this acquisition, WeightWatchers aims to transform itself from a traditional diet and weight-loss program into a modern clinical weight-management platform. It focuses on integrating prescription obesity treatments, including Glucagon Like Peptide-1 medications through telehealth services, and digital support tools. Sequence Weekend Health Inc. is a US-based clinical weight-loss and obesity care company that offers GLP-1 companion nutrition and weight-management support programs, including tailored nutrition guidance, protein and hydration targets, dietitian support, behavioral coaching, recipes, and GLP-1-specific lifestyle programs designed to complement GLP-1 medications.
Regional Outlook
North America was the largest region in the glucagon-like peptide-1 (GLP) companion food and nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market?
The glucagon-like peptide-1 (GLP) companion food and nutrition market consists of sales of nutrient-dense foods, medically formulated meal replacements, low-calorie snacks, and dietary supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Report 2026?
The glucagon-like peptide-1 (glp) companion food and nutrition market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the glucagon-like peptide-1 (glp) companion food and nutrition industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.14 billion |
| Revenue Forecast In 2030 | $11.66 billion |
| Growth Rate | CAGR of 29.6% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Consumer, Formulation Focus, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Nestlé S.A., Danone S.A., Arla Foods amba, Glanbia plc, Herbalife Ltd., BellRing Brands Inc., The Simply Good Foods Company |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |